Cargando…
Rethinking high-risk groups in COVID-19
Autores principales: | Vishnevetsky, Anastasia, Levy, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175875/ https://www.ncbi.nlm.nih.gov/pubmed/32388461 http://dx.doi.org/10.1016/j.msard.2020.102139 |
Ejemplares similares
-
COVID-19: A rethink of corticosteroid injection?
por: Little, Christopher P., et al.
Publicado: (2020) -
Rethinking Gain-of-Function Experiments in the Context of the COVID-19 Pandemic
por: Imperiale, Michael J., et al.
Publicado: (2020) -
Rethinking vulnerability through Covid‐19
por: Napier, A. David
Publicado: (2020) -
COVID-19: rethinking risk
por: Schwalbe, Nina, et al.
Publicado: (2020) -
B cell therapy and the use of RNA-based COVID-19 vaccines
por: Vishnevetsky, Anastasia, et al.
Publicado: (2021)